Find clinical trials for Lung Cancer in Toronto, ON
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Toronto, ON, CAN:
pemetrexed chemotherapy. The current standard of care for first-line Epidermal Growth Factor Receptor (EGFR) mutated Advanced Non-Small Cell Lung...
Phase 2
Toronto, Ontario, Canada and 9 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Toronto, Ontario, Canada and 210 other locations
Currently, the standard of care treatment for newly diagnosed, inoperable stage III non-small cell lung cancer is radiotherapy (RT) ...
Phase 2
Toronto, Ontario, Canada
The standard or usual treatment for this disease is pembrolizumab given by needle into the veins (IV).Some cancers shed DNA (circulating tum...
Phase 2, Phase 3
Toronto, Ontario, Canada and 10 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Toronto, Canada and 124 other locations
circulating tumour DNA (ctDNA) in the blood can help to predict whether giving adjuvant treatment after surgery can decrease the chance of the cancer...
Phase 2
Toronto, Ontario, Canada
This study is designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...
Phase 3
Toronto, Canada and 233 other locations
This study evaluates the use of SMS001 in patients with lung cancer. SMS001 is a new form of drug Paclitaxel. Doctors want to decid ...
Phase 2
Toronto, Ontario, Canada and 1 other location
KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung...
Phase 3
Brampton, Ontario, Canada and 156 other locations
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...
Phase 3
Toronto, CA, Canada and 182 other locations
Clinical trials
Research sites
Resources
Legal